These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27642066)

  • 1. A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials.
    Gayvert KM; Madhukar NS; Elemento O
    Cell Chem Biol; 2016 Oct; 23(10):1294-1301. PubMed ID: 27642066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems pharmacology to predict drug toxicity: integration across levels of biological organization.
    Bai JP; Abernethy DR
    Annu Rev Pharmacol Toxicol; 2013; 53():451-73. PubMed ID: 23140241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR Methods.
    Gini G
    Methods Mol Biol; 2016; 1425():1-20. PubMed ID: 27311459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of computational structure-based predictive toxicology in drug discovery.
    Mohan CG
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):417-26. PubMed ID: 21470184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Connectivity Map in drug discovery and development.
    Qu XA; Rajpal DK
    Drug Discov Today; 2012 Dec; 17(23-24):1289-98. PubMed ID: 22889966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory drug effects approached from human-derived data.
    Lötsch J; Knothe C; Lippmann C; Ultsch A; Hummel T; Walter C
    Drug Discov Today; 2015 Nov; 20(11):1398-406. PubMed ID: 26160059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology Strategies for Drug Discovery: Present and Future.
    Blomme EA; Will Y
    Chem Res Toxicol; 2016 Apr; 29(4):473-504. PubMed ID: 26588328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing toxicity risk when designing and selecting compounds in early drug discovery.
    Segall MD; Barber C
    Drug Discov Today; 2014 May; 19(5):688-93. PubMed ID: 24451294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repositioning and Target Finding Based on Clinical Evidence.
    Kaneko S; Nagashima T
    Biol Pharm Bull; 2020; 43(3):362-365. PubMed ID: 32115497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troubleshooting computational methods in drug discovery.
    Kortagere S; Ekins S
    J Pharmacol Toxicol Methods; 2010; 61(2):67-75. PubMed ID: 20176118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Approaches in Multitarget Drug Discovery.
    Scotti L; Ishiki HM; Duarte MC; Oliveira TB; Scotti MT
    Methods Mol Biol; 2018; 1800():327-345. PubMed ID: 29934901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Successes and Failures of Clinical Trials With Outer Product-Based Convolutional Neural Network.
    Seo S; Kim Y; Han HJ; Son WC; Hong ZY; Sohn I; Shim J; Hwang C
    Front Pharmacol; 2021; 12():670670. PubMed ID: 34220508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering Links Between Side Effects and Drugs Using a Diffusion Based Method.
    Timilsina M; Tandan M; d'Aquin M; Yang H
    Sci Rep; 2019 Jul; 9(1):10436. PubMed ID: 31320740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems Toxicology: Systematic Approach to Predict Toxicity.
    Kiani NA; Shang MM; Tegner J
    Curr Pharm Des; 2016; 22(46):6911-6917. PubMed ID: 27697024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiscale mathematical modeling to support drug development.
    Nordsletten DA; Yankama B; Umeton R; Ayyadurai VA; Dewey CF
    IEEE Trans Biomed Eng; 2011 Dec; 58(12):3508-12. PubMed ID: 22042123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety biomarkers in preclinical development: translational potential.
    Sasseville VG; Mansfield KG; Brees DJ
    Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance.
    McKim JM
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):188-206. PubMed ID: 20053163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considering the impact drug-like properties have on the chance of success.
    Yusof I; Segall MD
    Drug Discov Today; 2013 Jul; 18(13-14):659-66. PubMed ID: 23458995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach.
    Liu T; Altman RB
    J Chem Inf Model; 2015 Jul; 55(7):1483-94. PubMed ID: 26121262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.